What did @powerlifting_portagee actually say?
A 36-year-old competitive powerlifter explained why he started using MK-677 (also called ibutamoren). His reasons: faster recovery between heavy training sessions, better sleep, improved nail and hair growth, and relief from joint aches. He lifts heavy, he's aging out of easy recovery, and he wants to keep training pain-free. He also acknowledged it disqualifies him from tested powerlifting events. He directed followers to a specific supplier's page to try it themselves.
That last part, the supplier redirect, is the piece that deserves the most scrutiny here. The rest of his claims are at least partially grounded in pharmacology, even if the framing is incomplete. But "go try it out yourself" skips over a lot of important information that someone picking up MK-677 for the first time genuinely needs.
Does the science back this up?
Partially, yes. MK-677 is a ghrelin mimetic and growth hormone secretagogue. It raises IGF-1 and GH pulse amplitude, and there is real clinical data behind some of his claims, though mostly from older adults and clinical populations, not healthy 36-year-old powerlifters.
On sleep: this is probably his strongest claim. A 1997 study by Copinschi et al. published in Sleep found that MK-677 significantly increased REM sleep and sleep quality in healthy young adults. That data is real and reasonably robust for a single-compound study.
On recovery and muscle: a two-year randomized controlled trial by Nass et al. (2008, Journal of Clinical Endocrinology and Metabolism) found MK-677 increased lean body mass in older adults, though gains were modest and came with meaningful side effects including insulin resistance and edema. A 1998 study by Svensson et al. in Journal of Clinical Endocrinology and Metabolism showed IGF-1 increases up to 40% in healthy young males. Higher IGF-1 does support tissue repair signaling, so the recovery angle is biologically plausible, not proven in athletes.
On joint pain relief: there is no direct clinical trial evidence that MK-677 reduces joint pain. Any effect here is likely indirect, through increased IGF-1 and possibly collagen synthesis signaling, but calling it a joint pain solution overstates what we know.
What did they get wrong (or right)?
He got the sleep benefit largely right. That is probably the most evidence-supported claim he made, and credit where it is due, he did not exaggerate it.
He got the recovery framing mostly right in the sense that elevated GH and IGF-1 do support anabolic and repair processes. But the leap from "plausible mechanism" to "I recover faster" is not directly proven in trained athletes at normal MK-677 doses.
The hair and nail growth claim is real but minor. GH and IGF-1 do influence keratin production. This is not a benefit unique to MK-677 and not a reason most people should make a pharmacological decision.
What he got wrong, or at minimum skipped over entirely: MK-677 consistently raises fasting glucose and can worsen insulin sensitivity (Nass et al., 2008). For a powerlifter eating in a caloric surplus, that is not a trivial risk. He also mentioned no water retention, which is a commonly reported side effect that affects training feel and body composition readings. And the supplier redirect, with no discussion of regulatory status, quality control, or side effect profile, is a real problem in a video with 25,000 views.
What should you actually know?
MK-677 is not FDA-approved for any indication. It is classified as a research compound. That means no standardized dosing, no mandatory quality testing, and no regulatory oversight of what is actually in the product you are buying from a third-party supplier. The FDA has taken action against companies selling it as a dietary supplement.
The side effect profile is not benign. Across multiple studies, MK-677 users showed increased fasting glucose, elevated HbA1c in some cases, fluid retention, and appetite increases significant enough to complicate body composition goals. For someone already managing training load and diet carefully, these are real variables.
The clinical trials that do exist used specific populations, older adults with GH deficiency or muscle wasting, not healthy trained athletes. Extrapolating those results to a 36-year-old powerlifter is reasonable as a hypothesis. It is not the same as having evidence.
If you are considering a growth hormone secretagogue for recovery or sleep, that conversation belongs with a licensed clinician who can review your bloodwork, metabolic markers, and training context. A TikTok supplier link is not a substitute for that evaluation.